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Type-1 diabetes (T1D) is a metabolic disease involving the autoimmune destruction
of insulin-producing pancreatic beta cells. It is often diagnosed by the detection of
autoantibodies, typically those recognizing insulin itself or the 65-kDa isoform of glutamic
acid decarboxylase (GAD65). Oral insulin can be used to induce systemic immunological
tolerance and thus prevent or delay the onset of T1D, suggesting that combination
treatments with other autoantigens such as GAD65 could be even more successful.
GAD65 has induced oral tolerance and prevented T1D in preclinical studies but it is
difficult to produce in sufficient quantities for clinical testing. Here we combined edible
plant systems, namely spinach (Spinacia oleracea cv Industra) and red beet (Beta
vulgaris cv Moulin Rouge), with the magnICON R© expression system to develop a safe,
cost-effective and environmentally sustainable platform for the large-scale production
of GAD65. The superior red beet platform was extensively characterized in terms of
recombinant protein yields and bioequivalence to wild-type plants, and the product was
tested for its ability to resist simulated gastric digestion. Our results indicate that red
beet plants are suitable for the production of a candidate oral vaccine based on GAD65
for the future preclinical and clinical testing of T1D immunotherapy approaches.
Keywords: oral tolerance, autoimmune diabetes, immunotherapy, transient expression, red beet, molecular
farming, GAD65, magnICON R©
INTRODUCTION
Type 1 diabetes (T1D) is a disorder of glucose metabolism caused by the autoimmune destruction
of insulin-producing pancreatic beta cells. Currently, the only effective way to manage the disease is
lifelong daily insulin injections. There are∼422 million diabetics worldwide, with T1D accounting
for 5–10% of this population (You and Henneberg, 2016). Diabetic complications are a major cause
of morbidity and mortality in T1D patients, and alternative treatments that prevent or delay the
onset of T1D are therefore highly desirable.
Several immunological approaches have been explored to reduce the burden of T1D, and the
induction of systemic immunological tolerance by the oral administration of autoantigens is the
most promising strategy due to the specificity of the treatment and the negligible side effects. T1D is
often diagnosed by the detection of autoantibodies against insulin itself (specifically preproinsulin),
the 65-kDa isoform of glutamic acid decarboxylase (GAD65), the phosphatase IA-2 and/or the
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zinc transporter ZnT8 (Mauvais et al., 2016). These principal
autoantigens could be used for the induction of oral tolerance but
massive quantities of each protein are needed, and the treatment
is only effective in narrow dose ranges (Mowat et al., 2004).
The production of autoantigens for the induction of
oral tolerance requires a safe, highly scalable and cost-
effective heterologous production system. Plants meet these
criteria because they do not support the replication of
mammalian pathogens, production can be scaled up easily, and
plants do not require the expensive infrastructure associated
with cell-based systems, i.e., stainless-steel fermenters (Tusé
et al., 2014). Furthermore, edible plant tissues engineered to
produce recombinant proteins can be used for the direct oral
administration of autoantigens without extensive purification,
which is beneficial because up to 80% of biopharmaceutical
manufacturing costs relate to downstream processing (Wilken
and Nikolov, 2012; Buyel et al., 2015). The ability to grow
antigen-producing plants locally also eliminates the need for
transportation and a cold chain (Kwon et al., 2013). Among the
various strategies developed for the expression of recombinant
proteins in plants, transient expression in leafy crops using
deconstructed plant viruses achieves a superior performance in
terms of yields and speed, allowing the production of large
quantities of target proteins within a short time (Rybicki, 2010).
In particular, the magnICON R© system has been extensively used
in Nicotiana benthamiana as the gold standard production host,
but this tobacco-related species is not an ideal basis for oral
vaccines because alkaloids and other metabolites accumulate in
the leaves (Merlin et al., 2016).
GAD65 is currently under investigation in human clinical
trials as a means to prevent or delay T1D by inducing oral
tolerance (Ludvigsson, 2013). GAD65 has already been expressed
in several plant systems, and the catalytically inactive version
of the protein (GAD65mut) was found to be more stable than
the wild-type form, resulting in 10-fold higher yields (Avesani
et al., 2010). Furthermore, we have previously shown that
a truncated form of GAD65mut lacking the first 87 amino
acids (187GAD65mut) is more soluble than GAD65mut and
accumulates to higher levels in leaves when expressed using the
magnICON R© system (Merlin et al., 2016). Here we combined
the superior performance of the magnICON R© system with
two edible plant species to develop a new platform for the
large-scale production of GAD65 in plant tissue, in order
to determine the feasibility of edible plants as a means to
induce oral tolerance against T1D in preclinical and clinical
studies.
MATERIALS AND METHODS
Construction of Plant Expression Vectors
The magnICON R© Tobacco mosaic virus 3′ module pICH31070,
containing the GAD65mut and 187GAD65mut sequences, was
prepared as previously described (Avesani et al., 2014; Merlin
et al., 2016). The final vectors pICH31070.187GAD65mut,
pICH31070.GAD65mut, and pICH7410.GFP (3′ modules),
pICH20111 (5′module) and pICH14011 (integrase module) were
introduced into Agrobacterium tumefaciens strain GV3101 by
electroporation.
Transient Expression in Edible Plants
Spinach and red beet plants were grown in a growth chamber
(day/night temperatures of 23/21◦C, 12-h photoperiod, 65%
humidity). Five-week-old spinach and six-week-old red beet
plants were used for both syringe and vacuum agroinfiltration.
The bacteria were seeded into lysogeny broth (LB) medium
containing 50 µg/mL rifampicin and 50 µg/mL kanamycin
(pICH31070.187GAD65mut and pICH31070.GAD65mut)
or 50 µg/mL carbenicillin (pICH14011, pICH20111 and
pICH7410.GFP). For syringe agroinfiltration, overnight bacterial
cultures were collected by centrifugation at 4500 × g and
resuspended in two volumes of infiltration buffer (10 mM
MES pH 5.5, 10 mM MgSO4). Following incubation for 3 h at
room temperature, the GAD65mut, 187GAD65mut or GFP
3′ module suspension was mixed with equal volumes of the 5′
module and integrase module suspensions and the mixture was
used to infiltrate the leaves of spinach and red beet plants, with
each biological replicate comprising a pool of three infiltrated
leaves from different plants, sampled from 4 to 12 dpi for GFP
and from 2 to 14 dpi for the GAD65 forms. A mixture of the
5′ module and integrase module suspensions was used as a
negative control. For vacuum agroinfiltration, the bacteria were
inoculated in 200 mL of selective LB medium and grown to
saturation. The overnight culture was pelleted at 4500 × g for
20 min and resuspended in infiltration buffer to an OD600 of
0.35, 0.035 or 0.0035 (corresponding to 10−1, 10−2, and 10−3
dilutions, respectively). Following incubation for 3 h at room
temperature, the GAD65mut,187GAD65mut or GFP 3′ module
suspensions were mixed with equal volumes of the 5′ module
and integrase module suspensions and vacuum infiltrated into
the aerial parts of red beet plants dipped into the infiltration
suspension in a vacuum chamber (Thermo Fisher Scientific,
Waltham, MA, United States). Vacuum was applied for 3–5 min
using a VCP 80 pump (VWR, Radnor, PA, United States) with
a pressure of 90 mBar. Vacuum release was maintained for 45 s.
Each biological replicate comprised the infiltrated leaves from
a single plant, sampled at the maximum expression peak for
each recombinant protein. In some experiments, the detergent
Tween-20 (Sigma-Aldrich, St Louis, MO, United States) was
added to the infiltration suspension at different concentrations
(0.005, 0.01, and 0.05%). After both agroinfiltration procedures,
plants were returned in a growth chamber under standard
conditions.
Visualization and Absolute Quantification
of GFP
Leaves expressing GFP were viewed under UV illumination
using a B-100AP lamp and GFP was quantified using a
VICTOR3 Multilabel Counter (model 1420-011, PerkinElmer,
Waltham, MA, USA). The absolute GFP protein concentration
was determined by comparing different dilutions of total soluble
protein extracts to a standard curve prepared using recombinant
GFP (Roche Applied Science, Penzberg, Germany).
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Analysis of Recombinant Protein
Expression
Total soluble proteins were extracted from leaves by grinding
tissue samples to fine powder under liquid nitrogen. The
powder was resuspended in three volumes of extraction
buffer (50 mM sodium phosphate pH 8.0, 20 mM sodium
metabisulfite, 0.5% Tween-20) supplemented with Protease
Inhibitor Cocktail (Sigma-Aldrich). The same procedure was
used for freeze-dried and dried leaves, excluding the grinding
under liquid nitrogen. The homogenate was centrifuged at
30,000 × g for 40 min at 4◦C. Protein levels were determined
using the Quantum Protein Bicinchoninic Protein Assay Kit
(EuroClone, Pero, Italy). For western blot analysis, equal
volumes of total soluble protein were boiled for 10 min, then
separated by SDS-PAGE using 10% polyacrylamide for GAD65
variants and 12% polyacrylamide for GFP, and transferred
to a nitrocellulose membrane by electroblotting. The GAD65
variants were detected using an anti-GAD65/67 antibody
(G5163, Sigma-Aldrich) diluted 1:10 000, which recognizes
the C-terminal linear peptide shared by GAD65 and GAD67,
GFP was detected using the anti-GFP antibody ab290 (Abcam,
Cambridge, United Kingdom) diluted 1:20 000, and LHCB2
was detected using a specific antibody kindly provided by Prof.
R. Bassi, diluted 1:10,000, all followed by incubation with a
secondary horseradish peroxidase-conjugated rabbit anti-mouse
IgG, diluted 1:10,000 (A6154, Sigma-Aldrich). The signal was
detected using ECL Select western blotting detection reagent (GE
Healthcare, Little Chalfont, United Kingdom). The ChemiDocTM
system (Bio-Rad Laboratories, Hercules, CA, United States)
was used to capture chemiluminescent signals and images
were analyzed using Quantity One 1-D Analysis Software
(Bio-Rad). The relative and absolute levels of the GAD65
variants were determined using different concentrations of
recombinant human GAD65 (Dyamid Diagnostics, Stockholm,
Sweden).
Radiobinding Assay for GAD65 and
187GAD65mut Autoantibodies
The immunoreactivity of 187GAD65mut was evaluated
by testing autoantibodies against wild-type GAD65 and
187GAD65mut in serum samples from 94 subjects newly
diagnosed with T1D (recruited consecutively between 2006 and
2016) and from 106 healthy control subjects.
The 187GAD65mut sequence was cloned in the pCRTM
II TOPO vector using the TOPO TA cloning kit (Thermo
Fisher Scientific) according the manufacturer’s instructions. The
fragment was initially amplified from pENTR.187GAD65mut as
a template using Platinum high-fidelity Taq DNA polymerase
(Thermo Fisher Scientific), forward primer- 5′-AAG AAT TCA
ATT CAC CAT GAA CTA CGC GTT TCT CCA T-3′ and reverse
primer 5′-CGT CTA GAT TAT TAT AAA TCT TGT CCA AGG
CGT-3′. The resulting plasmid was introduced into chemically
competent One-shot TOP 10 Escherichia coli cells (Thermo
Fisher Scientific). Transformants were checked for the correct
insert using the cloning primers and M13 primers provided in
the TOPO TA kit, and another primer pair identifying a 147-bp
fragment within the 187GAD65mut clone (forward primer 5′-
AGG GAT TGA TGC AGA ATT GC-3′ and reverse primer
5′-CCC TCC ACA TCA GCC ATA GT-3′). Two colonies among
those positive for the correct insert were grown overnight in LB
medium containing 50 µg/mL kanamycin and plasmid DNA was
purified using a commercial kit (Qiagen, Hilden, Germany).
GAD65 and 187GAD65mut were 35S-radiolabeled
by coupled in vitro transcription and translation using
rabbit reticulocyte lysate (Promega Corp., Madison, WI,
United States) and 35S-methionine (PerkinElmer) according to
the manufacturer’s instructions. In the autoantibody assays,
20,000 cpm of 35S-GAD65 or 35S-187GAD65mut was
immunoprecipitated in duplicate with human serum at a dilution
of 1:25. The immunocomplexes were separated in 96-multiwell
plates (Millipore, Bedford, MA, United States) using Protein
A-Sepharose (GE Life Sciences, Uppsala, Sweden) as previously
described (Falorni et al., 1995). Finally, immunoprecipitated
radioactivity was evaluated in a Top Count-NXT microplate
scintillation counter (Packard Bioscience Co., Meriden, CT,
United States) against a positive standard serum and two
negative standard sera. Levels of autoantibodies were expressed
as a relative index according to the following formula: (cpm
sample – mean cpm negative controls)/(cpm positive controls –
mean cpm negative controls). The area under a ROC curve for
diagnostic sensitivity and specificity was determined and the
best cut-off value for each assay was calculated according to the
Youden index (Cantor and Kattan, 2000).
Plant Material Processing
Vacuum agroinfiltrated red beet leaves expressing
187GAD65mut sampled at the expression peak were frozen
in liquid nitrogen, stored at −80◦C, lyophilized for 72 h using
an LIO5P 4k freeze-dry system in a vacuum at −50◦C and
0.036 mBar, or dried in a stove at 50◦C for 10–11 h. Lyophilized
and heat-dried leaf material was ground into fine powder using
respectively an ordinary coffee grinder or by mortar and pestle.
The powder was stored in a sealed container with silica gel at
room temperature to exclude moisture.
Simulation of Gastric Digestion
Gastric digestion was simulated by vortex homogenizing
100 mg of grinded freeze-dried red beet leaves expressing
187GAD65mut, obtained as described in the previous
paragraph, in 6 mL PBS (8 g/L NaCl, 0.2 g/L KCl, 1.44 g/L
Na2HPO4, 0.24 g/L KH2PO4 pH 7.4). The samples were adjusted
to pH 2 with 6 M HCl and 4 mg/mL pepsin from porcine
gastric mucosa (P7012, Sigma-Aldrich) in 10 mM HCl to
obtain a final pepsin concentration of 1 mg/mL or a ratio of
1:20 to total soluble protein. The samples were shaken for
120 min at 37◦C, adjusted to pH 6 with 1 M NaOH to inactivate
pepsin. 750-µL aliquots were centrifuged at 20,000 × g for
30 min at 4◦C and the supernatant and pellet samples were
both analyzed by western blot analysis as described above.
To analyze the pellet, it was resuspended in one supernatant
volume of loading buffer. A sample treated according to the
protocol above but without pepsin was used as a negative
control. Three biological replicates were prepared for every
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sample. For the analysis of cell integrity, the freeze-dried and
heat-dried samples were processed as above, but without the
pepsin solution and at different pH values (7.4 or 2). This
analysis was performed using one biological replicate for each
sample.
Bioburden Assessment
We homogenized 100 mg of freeze-dried red beet leaves
expressing 187GAD65mut (or non-infiltrated controls) in 8 ml
sterile PBS (pH 7.4) vortexed for 1 min and transferred 1 ml
onto LB medium without antibiotics or containing (i) 50 µg/mL
rifampicin, (ii) 50 µg/mL each of rifampicin and carbenicillin,
(iii) 50 µg/mL each of rifampicin and kanamycin, or (iv)
50 µg/mL each of rifampicin, carbenicillin and kanamycin. The
residual bacterial charge was examined after 3 days at 28◦C and
represented as colony forming units (CFU)/mL. Three biological
replicates were tested for each sample.
Extraction of Metabolites
For the extraction of primary metabolites, infiltrated and
non-infiltrated red beet plants were processed as described
by Antonio et al. (2007) with modifications. Leaves were
ground to powder in liquid nitrogen and 30 mg of the leaf
powder was extracted by vortexing for 30 s with 750 µl
ice-cold 7/3 (v/v) methanol/chloroform. After incubation at
−20◦C for 2 h, we added 600 µl of cold water and the
extracts were centrifuged at 17900 × g at 4◦C for 10 min.
The upper hydroalcoholic phase was collected and evaporated
in a Heto Holton Maxi-Dry Plus Vacuum (Thermo Fisher
Scientific). The pellets were resuspended in 300 µl of 50/50 (v/v)
acetonitrile/water as previously described (Antonio et al., 2008).
Samples were sonicated for 3 min and passed through 0.2-µm
Minisart RC4 membrane filters (Sartorius-Stedim, Göttingen,
Germany). For the extraction of secondary metabolites, 300 mg
of the leaf powder was processed essentially as described by
Commisso et al. (2017) but using 100% methanol as the solvent.
Polar lipids were extracted from 200 mg of leaf powder as
described by Negri et al. (2017). Prior the final filtration,
supernatants were diluted 1:5 with methanol, sonicated for
3 min and centrifuged at 17900 × g at 4◦C for 10 min. The
supernatants were passed through 0.2-µm Minisart RC4 filters
as above.
FIGURE 1 | Time-course analysis of GFP expression in agroinfiltrated red beet and spinach leaves. Western blot analysis (A,B) and corresponding loading controls
(RuBisCO large subunit) stained with Coomassie Brilliant Blue (C,D) of GFP-containing protein extracts from leaf samples collected from 4 to 14 dpi. The GFP
content of each leaf protein extract was quantified by fluorescence measurement (E,F). Left panels show samples from agroinfiltrated red-beet leaves, and right
panels show samples from agroinfiltrated spinach leaves. Each lane was loaded with 3.5 and 30 µg of TSP for western blot and Coomassie staining, respectively.
The western blot was probed with an anti-GFP antibody. Side numbers indicate molecular mass markers in kDa. p.c., positive control, 10 ng of commercial
recombinant human GAD65; n.c., negative control, extract from leaves infiltrated solely with A. tumefaciens carrying magnICON R© 5′- and integrase modules.
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LC-MS Analysis
Samples were analyzed at 0.2 mL/min by high-performance
liquid chromatography (HPLC) using a Beckman Coulter 508
autosampler (Beckman Coulter, Fullerton, CA, United States)
maintained at 4◦C, coupled with a Beckman Coulter Gold 127
HPLC device. Primary metabolites (5 µL injection volume) were
separated using a VisionHT HILIC guard column (7.5× 2.1 mm,
3 µm particle size; Grace, Columbia, MD, USA) in line with
an Ascentis Express HILIC column (150 × 2.1 mm, 2.7 µm
particle size; Supelco, Sigma-Aldrich). The solvents were water
plus 20 mM ammonium formiate (A) and 95% acetonitrile, 5%
water plus 10 mM ammonium formiate (B). Starting at 100% B
for 10 min, the gradient declined to 85% B in 15 min followed
by a hold for 5 min, then to 50% B in 10 min followed by a
hold for 30 min, and then increased to 100% B in 1 min with
a final equilibrium for 29 min. Secondary metabolites and polar
lipids (10 µL injection volume) were analyzed using a C18 guard
column (7.5 × 2.1 mm, 5 µm particle size) in line with an HP
C18 column (150 × 2.1 mm, 3 µm particle size) both sourced
from Alltima (Nicholasville, KT, United States). The solvents
were water plus 0.05% formic acid (A) and acetonitrile plus 0.05%
formic acid (B) for secondary metabolites, or 100% acetonitrile
(B) for polar lipids. Samples were separated following gradients
as reported by Commisso et al. (2017) for secondary metabolites
and by Negri et al. (2017) for polar lipids.
The HPLC system was coupled to an Esquire 6000 ion trap
mass spectrometer (Bruker Corp., Billerica, MA, United States)
equipped with an electrospray ionization (ESI) source for
the analysis of primary and secondary metabolites, whereas
atmospheric-pressure chemical ionization (APCI) was used to
detect polar lipids. Samples were ionized in negative and positive
modes. The ESI values were 50 psi and 350◦C for the nitrogen
nebulizing gas and 10 L/min for the drying gas. For APCI, the
same values were used and the vaporizer was set at 450◦C. The
mass spectrometer scanned the 50–1500 m/z range and the target
masses were set at 200 m/z for primary metabolites, 400 m/z
for secondary metabolites and 700 m/z for polar lipids. LC-MS
data were recorded and processed with Esquire Control v5.2
and Data Analysis v3.2 (Bruker Corp.), respectively. The latter
was used to convert.d raw data into net.cdf files. MZmine v21
was used for the detection, deconvolution and alignment of the
m/z features to create the data matrices used for multivariate
1http://mzmine.github.io/
FIGURE 2 | GFP expression in red beet following agroinfiltration with different A. tumefaciens titers. (A) UV illuminated images of infiltrated red beet leaves expressing
GFP (right) and corresponding negative controls (n.c., left). (B) GFP content of infiltrated leaves quantified by fluorescence analysis of leaf protein extracts and shown
as mean GFP percentage as a proportion of TSP in three biological replicates ± standard deviation.
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statistical analysis. Quality controls were prepared by mixing
equal parts of wild-type, negative control and 187GAD65mut
extracts. These samples were analyzed at the beginning, in the
middle and at the end of each experiment.
Statistical Analysis
For the autoantibody assays, diagnostic sensitivity was calculated
as the percentage of T1DM sera that scored positive and
diagnostic specificity as the percentage of healthy control sera
that scored negative. Diagnostic accuracy was calculated as the
AUC for a binary diagnostic test (positive/negative) (Cantor and
Kattan, 2000). The concordance of qualitative results between
different determinations was determined using the Cohen’s κ
coefficient of inter-rater agreement according to the classification
of sera as positive or negative (Altman, 1995). Cohen’s κ
coefficient provides a measure of the overlapping of classifications
by different methods, and the gradation of the Cohen’s κwas<0.2
poor, 0.2–0.4 fair, 0.4–0.6 moderate 0.6–0.8 good, 0.8–1 very good
(Landis and Koch, 1977). The Intra-class correlation coefficient
(ICC value ranging from 0 to 1), defined as the proportion of
variance of an observation due to between-subject variability in
the true scores, was used to assess rating reliability by comparing
the variability of different ratings of the same subject to the total
variation across all ratings and all subjects. The type of ICC was
2,1 (Shrout and Fleiss, 1979). A high ICC indicates little variation
between the scores assigned to each item by the raters. Gradation
of ICC was 0–0.2 poor agreement, 0.3–0.4 fair agreement,
0.5–0.6 moderate agreement, 0.7–0.8 strong agreement, >0.8,
almost perfect agreement (Shrout and Fleiss, 1979). Multivariate
statistical analysis including PCA and OPLS-DA was carried out
as described by Negri et al. (2017) for the LC-MS data and a
p-value< 0.05 was considered statistically significant.
RESULTS
Host Selection for Transient Expression
and Optimization of the Infiltration
Protocol
We compared the suitability of the magnICON R© system for the
production of recombinant proteins in the leaves of spinach
(Spinacia oleracea cv Industra) and red beet (Beta vulgaris cv
Moulin Rouge) plants initially using green fluorescent protein
(GFP) as a model product. We conducted a time-course
expression analysis and compared GFP levels on the day of
maximum expression in each host. Suspensions of A. tumefaciens
carrying GFP expression vectors were manually infiltrated into
the leaves of both species and pools of three leaves were
sampled daily, beginning 4 days post-inoculation (dpi) and
finishing 12 dpi. Western blot analysis of leaf extracts and
the quantification of GFP by fluorescence analysis revealed an
expression peak 9 dpi in red beet leaves and 11 dpi in spinach
leaves (Figure 1). The peak expression level of GFP in red beet
was 544.9 ± 10.9 µg/g fresh leaf weight (FLW), which was
significantly higher (Student’s t-test, p < 0.01) than in spinach
(113.4 ± 0.3 µg/g FLW). We therefore selected red beet as the
expression host for all subsequent experiments.
The infiltration protocol was switched to the vacuum
method because this is more suitable for large-scale vaccine
FIGURE 3 | Comparison of GAD65mut and 187GAD65mut expression levels in red beet leaves. (A) Western blot analysis and (B) corresponding loading control
(RuBisCO large subunit) stained with Coomassie Brilliant Blue, representing extracts from three red beet leaves expressing GAD65mut (left) and 187GAD65mut
(right). The western blot was probed with an anti-GAD antibody (the lanes were loaded with 20 µL of extract for GAD65mut and 1 µL of extract for 187GAD65mut).
Equal amounts of protein extract (10 µL/lane) were loaded for Coomassie staining. Side numbers indicate molecular mass markers in kDa. p.c., positive control,
10 ng of commercial recombinant human GAD65; n.c., negative control, extract from leaves solely infiltrated with A. tumefaciens carrying magnICON R© 5′ and
integrase modules. (C) Relative expression levels of the two protein forms, plotted as mean values of densitometric analysis of western blot image, using positive
control band as reference.
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manufacturing (Chen et al., 2013). We tested two different
vacuum infiltration parameters, namely the bacterial titer and the
concentration of detergent.
We tested a dilution series of an overnight culture of
A. tumefaciens ranging from 10−1 to 10−3 and found that
higher bacterial titers produced greater GFP yields (Figure 2).
The maximum GFP yield was achieved at the lowest dilution
(10−1, equivalent to an OD600 of ∼0.35) and this was used in
subsequent experiments. The concentration of Tween-20 in the
infiltration buffer was tested in the range 0.005–0.05% because
the amount of detergent has been shown to influence the protein
yields in vacuum-infiltrated plants (Joh et al., 2005). However,
UV illumination of the infiltrated plants and subsequent GFP
quantification as above revealed no significant difference in
protein yields (Student’s t-test, p< 0.01) among plants infiltrated
with different detergent concentrations or in the absence of
detergent (data not shown). However, the presence of the
detergent reduced the amount of time required to infiltrate the
plant tissue so we selected a mid-range concentration of 0.01%
for further infiltration experiments.
Selection of the Best-Performing Form
of GAD and Immunological
Characterization
Various forms of the target molecule GAD65 have previously
been expressed in plants, and production has been optimized
by expressing a catalytically inactive mutant form of the protein
(GAD65mut) that retains the immunogenic properties necessary
to induce oral tolerance (Avesani et al., 2010). More recently, an
FIGURE 4 | Diagnostic sensitivity and specificity of the GAD65Ab and 187GAD65mut assays. Receiving operator characteristic (ROC) curves for the (A) GAD65Ab
and (C) 187GAD65mutAb assays, and classification of negative and positive samples by the best cut-off value according to the Youden index for the (B) GAD65Ab
and (D) 187GAD65mutAb assays.
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N-terminally truncated form of GAD65mut (187GAD65mut)
was expressed in N. benthamiana and tobacco (N. tabacum)
to increase the solubility and stability of the protein. This
form of the protein also accumulated at higher levels than its
full-length counterpart when expressed in N. benthamiana using
the magnICON R© system (Merlin et al., 2016).
The same magnICON R© vectors used in our previous study
(Merlin et al., 2016) were used here to express GAD65mut and
187GA65mut in red beet leaves. A time-course analysis from
day 2 to 14 revealed that both protein forms were expressed but
with different yields and accumulation profiles (Supplementary
Figure 1). The peak expression of GAD65mut was 5 dpi and
that of 187GAD65mut was 11 dpi (Figure 3). Furthermore, the
peak expression level of 187GAD65mut was more than 20-fold
higher than its full-length counterpart (Figure 3). The truncated
protein was therefore selected as the preferred T1D oral vaccine
candidate.
The immunoreactivity of 187GAD65mut was compared
to that of the full-length wild-type protein (GAD65) by
radioimmunoassay using sera from 94 new-onset T1D patients
and from 106 healthy control subjects. This analysis is based
on protein recognition by autoantibodies present in sera from
T1D patients, thus providing insight into the immunological
features and conformation of the proteins. The immunoreactivity
of the two molecules was evaluated in terms of their diagnostic
sensitivity and specificity by receiver operating characteristic
(ROC) curve analysis to distinguish T1D and control samples.
Using the best cut-off value calculated according to the Youden
index (0.022 for the GAD65 antibody assay and −0.003 for the
187GAD65mut antibody assay) both assays achieved satisfactory
diagnostic accuracy, with area under the curve (AUC) values
and corresponding 95% confidence intervals (95% CI) of 0.927
for GAD65 (95% CI 0.882–0.959) and 0.924 for 187GAD65mut
(95% CI 0.879–0.957) and no statistically significant differences
(p = 0.8696) between them (Figure 4).
The concordance of qualitative results (classification of
subjects as positive or negative by the two assays) showed
agreement in 85 of 94 (90%) T1D sera and 104 of 106 (98%)
healthy control sera, with a very good Cohen’s κ coefficient
of 0.874 (95% CI 0.802–0.946) for the general agreement. To
determine the inter-assay concordance for GAD65 antibody
levels, the intraclass correlation coefficient (ICC, ranging from 0
to 1) was calculated for all assays couples. In this type of analysis,
a high ICC indicates that there is little variation among GAD65
antibody levels in each serum sample as determined by the two
assays, and we observed strong to almost perfect agreement
(ICC = 0.951).
Oral Vaccine Candidate Design
The combination of 187GAD65mut as the preferred product,
red beet as the preferred host and the corresponding best-
performing protocol for transient expression in terms of
recombinant protein accumulation was selected for the
production of a T1D oral vaccine candidate. The concentration
of 187GAD65mut was measured by densitometry on western
blots of red beet leaf extracts using known amounts of purified
recombinant GAD to produce a standard curve. The truncated
protein form accumulated to levels of 201.4 ± 29.3 µg/g FLW in
red beet leaves at 11 dpi (Supplementary Figure 2).
One of the challenges associated with plant-derived oral
vaccines is to ensure that the integrity of the immunoreactive
target molecule is maintained in the plant tissue used for
oral administration. Plant-derived biopharmaceuticals for oral
delivery are often administered as minimally processed dried
biomass (Merlin et al., 2017). To evaluate the stability of
187G AD65mut in dehydrated leaves, western blot analysis
was carried out after freeze-drying/lyophilization or heat-drying
treatments, in comparison to untreated (only frozen) tissue
(Figure 5). The dehydration of fresh leaf material reduced the
tissue weight by ∼90% due to the removal of water from the
plant cells (data not shown) and maintained the integrity of
target protein. However, freeze-drying/lyophilization achieved
a higher yield of immunoreactive protein than heat drying
(Figure 5).
Another important challenge associated with oral vaccines is
to ensure the delivery of bioactive molecules to the gut-associated
lymphoid tissue (GALT), which means that the structural
FIGURE 5 | Evaluation of protein stability after different dehydration
treatments. (A) Western blot analysis and (B) corresponding gel stained with
Coomassie Brilliant Blue representing three independent extracts from leaves
expressing 187GAD65mut. After sampling, leaves were directly frozen (fresh),
heat-dried at 50◦C for 10–11 h (heat dried) or lyophilized at –50◦C, 0.04 mBar
for 72 h (freeze dried). Total soluble proteins were extracted at different
tissue:buffer ratios to consider water loss due to dehydration. Different
amounts of protein extracts were loaded for western blot analysis:
0.25 µL/lane for the “fresh” and “freeze-dried” extracts, 1 µL of “heat-dried”
extract. Equal amounts of protein extract (10 µL/lane) were loaded for
Coomassie staining. The western blot was probed using an anti-GAD
antibody. Side numbers indicate molecular mass markers in kDa. n.c.,
negative control, extract from leaves infiltrated solely with the A. tumefaciens
carrying magnICON R© 5′ and integrase modules.
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integrity of the vaccine must be maintained as it moves through
the gastric tract. Plant cells are thought to facilitate this by
encapsulating recombinant antigens and protecting them from
degradation caused by the low pH and digestive enzymes in the
stomach (Kohli et al., 2014; Su et al., 2015; Xiao et al., 2016). We
therefore tested the stability of 187GAD65mut in plant tissue
after exposure to low pH treatment and a simulation of gastric
digestion.
FIGURE 6 | In vitro simulated gastric digestion of 187GAD65mut in freeze-dried red beet leaves. (A–D) Western blot analysis and (E,F) corresponding gels stained
with Coomassie Brilliant Blue representing three independent extracts of leaves expressing 187GAD65mut after simulated gastric digestion. Pepsin was added at a
final concentration of 1 mg/mL (A,C,E) or at a ratio of 1:20 to the TSP (B,D,F) to 100 mg of lyophilized tissue. Samples without enzyme were used as controls (no
pepsin). Supernatants (s) and pellets (p) obtained in the final centrifugation after treatment were loaded for SDS-PAGE analysis (24 and 16 µl, respectively). The
western blot was probed with anti-GAD (A,B) and anti-LHCB2 (C,D) antibodies. Side numbers indicate molecular mass markers in kDa.
TABLE 1 | Residual bacterial charge analysis.
Residual bacterial charge
No antibiotics Rifampicin Rifampicin Carbenicillin Rifampicin Kanamycin Rifampicin Carbenicillin Kanamycin
187GAD65mut 0 0 0 0 0
Wild-type 0 0 0 0 0
CFU/mL recorded when extracts of 100 mg freeze-dried red beet leaves expressing 187GAD65mut and non-infiltrated controls were incubated for 3 days at 28◦C on
LB medium without antibiotics and containing (i) 50 µg/mL rifampicin, (ii) 50 µg/mL each of rifampicin and carbenicillin, (iii) 50 µg/mL each of rifampicin and kanamycin,
or (iv) 50 µg/ml each of rifampicin, carbenicillin and kanamycin. The analysis was performed using three biological replicates for each sample.
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We hypothesized that plant cells remain intact after tissue
grinding and dehydration, and therefore the intracellular proteins
should not be released in the extraction buffer and hence would
be protected from acidic conditions that would otherwise cause
them to precipitate (Fink et al., 1994). Western blot analysis of
the soluble and insoluble fractions produced when dried plant
tissue was resuspended in buffer with a near neutral pH revealed
that187GAD65mut was partially solubilized, suggesting that leaf
grinding and drying disrupts at least some cells (Supplementary
Figure 3A). Under acidic conditions, the 187GAD65mut signal
was observed only in the insoluble fraction, probably reflecting
the protein content of unbroken cells, whereas the solubilized
187GAD65mut precipitated due to low pH (Supplementary
Figure 3A). The distribution of 187GAD65mut in the different
samples matched the distribution of total soluble protein, as
demonstrated by staining the gel with Coomassie Brilliant Blue
(Supplementary Figure 3B). These results confirmed that freeze-
drying/lyophilization was the best treatment for the preparation
of the vaccine candidate.
Next, we carried out a simulated acidic digestion of the freeze-
dried material using two different concentrations of the porcine
gastric enzyme pepsin, based on previously published reports
(Elless et al., 2000; Schulz et al., 2015). Western blot analysis of
the digested samples demonstrated that the recombinant protein
was degraded under both treatment conditions (Figure 6). We
carried out an additional western blot to detect the endogenous
antenna complex protein LHCB2, which is localized within
the chloroplast thylakoids and is thus protected by multiple
subcellular membranes. We did not detect a signal for this
protein either, indicating that even subcellular compartments lose
their integrity under acid digestion conditions and that targeting
187GAD65mut to accumulate within a subcellular compartment
is unlikely to protect it from degradation.
We also tested the agroinfiltrated red-beet leaves for residual
bacterial load by plating resuspended freeze-dried tissue onto
growth medium in the presence of different antibiotics. Our
results indicated that the treatment used to prepare the oral
vaccine candidate completely removed any bacterial bioburden
from the samples (Table 1).
Assessment of the Metabolic
Bioequivalence of 187GAD65mut and
Control Red Beet Plants
Fingerprints of primary and secondary metabolites and
polar lipids were generated by liquid chromatography mass
spectrometry (LC-MS) from nine red beet plants transiently
expressing 187GAD65mut, nine agroinfiltrated controls
(infiltrated with wild-type A. tumefaciens) and nine wild-type
controls (no infiltration).
Primary metabolites were analyzed by hydrophilic interaction
liquid chromatography (HILIC)-MS, whereas secondary
metabolites and polar lipids were analyzed by reversed-phase
(RP)LC-MS. The chromatograms are shown in Figure 7 and
Supplementary Figure 4. The metabolic profiles were then
processed by unsupervised principal component analysis (PCA).
For the primary metabolites, one principal component explained
31.1% of the total variance for the negative dataset (Figure 8A)
FIGURE 7 | LC-MS base peak chromatograms of wild-type, negative control and 187GAD65mut-expressing plants. The data were acquired in negative ionization
mode. Primary metabolites (A–C), secondary metabolites (D–F), and the lipids (G–I) are shown for one wild-type, negative control and 187GAD65mut plant each.
The gray boxes show the chromatographic zone that was not excluded from analysis. The bottom bars highlight the solvent gradients in terms of B solvent
percentage (white: 0%; gray: 50%; black: 100%).
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FIGURE 8 | Multivariate statistical analysis outputs for primary metabolites. (A,B) PCA score scatter plots of primary metabolites analyzed in negative and positive
ionization mode. (C,D) OPLS-DA score plots highlighting the two imposed classes. White circles, wild-type plants; gray boxes, negative controls; black diamonds,
187GAD65mut-expressing plants. (E,F) S-loading plots showing metabolites correlating [pq(corr)] with a specific class. Black triangles, the putative metabolites.
whereas three principal components explained 47.6% of the total
variance for the positive dataset (Figure 8B). For the secondary
metabolites, two principal components explained 40.3% of the
total variance in the negative dataset (Figure 9A), whereas three
principal components explained 60.7% of the total variance
in the positive dataset (Figure 9B). For both the primary and
secondary metabolites, PCA revealed no separation between
the 187GAD65mut and infiltrated negative control plants,
but the wild-type plants formed a separate cluster. Orthogonal
projections to latent structures discriminant analysis (OPLS-DA)
was then used to compare the infiltrated and non-infiltrated
plants in terms of both primary (Figures 8C,D) and secondary
(Figures 9C,D) metabolites. The S-loading plots revealed
primary metabolites (Figures 8E,F and Table 2) and secondary
metabolites (Figures 9E,F and Table 2) with pq(corr) values
lower than −0.8 or higher than 0.8, indicating specific classes
(Zampieri et al., 2014). The imposition of three different classes
(187GAD65mut vs. agroinfiltrated control vs. wild-type) or two
classes (187GAD65mut vs. agroinfiltrated control, excluding
wild-type) showed no statistically significant differences among
the groups (data not shown). Finally, PCA revealed no clustering
within the positive or negative data matrices representing the
polar lipid extracts (Supplementary Figure 5).
DISCUSSION
More than 100 clinical trials for the treatment of autoimmune
diabetes are currently registered on www.clinicaltrials.gov,
including more than 30 using immunoregulatory strategies to
stop or prevent the destruction of pancreatic beta cells. One of
these trials involved the oral administration of insulin for the
prevention of T1D in relatives at risk of developing the disease
(NCT00419562). The amount of oral insulin administered in
this study is 7.5 mg per day for 7–8 years or until the required
amount of information has been gathered. The first results
indicate an average 31 months delay in the progression to
T1D in a subset of 55 subjects among 560 enrolled individuals
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FIGURE 9 | Multivariate statistical analysis of secondary metabolites analyzed in negative and positive ionization modes. (A,B) PCA score plots. (C,D) OPLS-DA
score plots with the two attributed classes. (E,F) S-loading plots showed the most correlating putative metabolites. Symbols are the same as explained in Figure 8.
(Greenbaum, 2017). This clinical program was possible thanks
to the cost-effective production of large amounts of insulin
in recombinant microbes (Baeshen et al., 2014) and the
dramatic results obtained in a subset of patients paves the
way toward future immunomodulatory strategies using other
T1D autoantigens such as GAD65. The oral administration
of GAD65 is likely to be particularly beneficial in subjects
that test positive for autoantibodies against GAD65 but not
insulin, because such individuals are not expected to respond to
oral insulin. Furthermore, combinatorial approaches involving
the concomitant administration of multiple autoantigens would
extend the protective benefits of oral tolerance and would
address subjects testing positive for more than one type of
autoantibody (Lernmark and Larsson, 2013). However, massive
quantities of clinical-grade autoantigens would be required to
test this approach (several kilograms of pure protein for each
phase III clinical trial), so a cost-effective and highly efficient
production platform for recombinant autoantigens would be
beneficial for clinical development and would be mandatory
should the approach be rolled out more generally.
Insulin is a relatively simple polypeptide and microbial
production is adequate for this product. In contrast, GAD65 is
a more complex protein and alternative production platforms are
required for the cost-effective manufacture of sufficient quantities
of GAD65 with the necessary quality attributes (Merlin et al.,
2014). Plants provide a versatile platform for the production of
recombinant proteins, particularly for oral vaccine development,
because edible plant tissues can be used as a vehicle for vaccine
administration without extensive processing and purification.
Many edible species and plant organs have been considered as
platforms for recombinant protein production, and the ability to
express proteins in the leaves of some edible species using the
deconstructed magnICON R© expression system based on Tobacco
mosaic virus has already been demonstrated (Marillonnet et al.,
2005).
We previously used the magnICON R© system to demonstrate
proof of principle for the expression of human GAD65
derivatives in N. benthamiana (Merlin et al., 2016). However,
N. benthamiana is not generally regarded as an edible species
due to the alkaloids and other metabolites that accumulate in
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TABLE 2 | Putative class-characterizing metabolites.
ID m/z rt pq(corr)
Primary metabolites
Negative datamatrix
4 193,76 26,03 −0,979665
46 388,72 25,95 −0,894626
44 367,59 26,64 −0,872155
Positive datamatrix
2 195,82 25,97 −0,982993
90 391,09 26,02 −0,924073
11 210,04 45,21 −0,886428
36 193,00 45,17 −0,873365
25 254,12 26,34 −0,868975
47 333,12 26,61 −0,841397
208 218,23 25,88 −0,821996
80 254,13 27,43 −0,815249
220 159,06 44,42 0,933643
Secondary metabolites
Negative datamatrix
249 212,90 27,98 −0,839398
104 386,66 13,55 0,807645
4 190,71 3,27 0,813981
67 410,91 2,64 0,82496
15 110,81 3,35 0,835718
6 536,03 2,60 0,836376
85 416,88 24,30 0,836501
11 193,71 2,79 0,945718
Positive datamatrix
9 343,07 2,67 −0,93146
7 196,08 2,75 −0,928641
76 493,21 21,97 −0,868173
43 560,18 2,71 −0,855664
28 329,35 2,77 −0,841778
26 218,31 2,59 −0,830092
31 423,17 16,75 −0,829772
22 348,93 3,16 −0,813145
78 428,84 2,69 −0,808734
29 447,17 24,56 −0,803155
Legend: m/z: mass to charge ratio; rt: retention time.
Comparison of putative primary and secondary metabolites characterizing a
specific class [pq(corr) < −0.8 and >+0.8] between infiltrated and non-infiltrated
(wild-type) plants.
the leaves, and alternative crops are needed for the routine
production of oral vaccines. We therefore compared two edible
crops – spinach and red beet – for their ability to produce
recombinant proteins efficiently, using GFP as a model. Red beet
was the most suitable, achieving higher yields of GFP with our
standard agroinfiltration method, perhaps reflecting the larger
intercellular spaces in beet leaves compared to spinach (data
not shown). We then tested a range of vacuum agroinfiltration
parameters to determine the optimal protocol in red beet, given
that the standard protocol is optimized for tobacco species, which
have even larger intercellular spaces than red beet (Marillonnet
et al., 2005). We found that optimal infiltration was achieved with
a higher bacterial titer than typically used in tobacco, but that the
yields were not as high. The concentration of detergent did not
appear to play a significant role in the efficiency of expression
and we therefore chose conditions that allowed infiltration to be
completed in the shortest time.
The form of GAD for expression was selected by comparing
GAD65mut with the truncated form 187GAD65mut, the latter
providing to be superior in red beet as previously reported
in N. benthamiana plants agroinfiltrated with magnICON R©
vectors (Merlin et al., 2016). We have previously confirmed the
immunoreactivity of 187GAD65mut but a comparison with the
full-length wild-type counterpart has not been reported. This
is an important control reference because wild-type GAD65
is currently being used in human clinical trials and for
T1D diagnosis. Accordingly, we found that wild-type GAD65
and 187GAD65mut behave in a similar manner in terms
of immunoreactivity toward conformational autoantibodies
present in T1D patient sera, indicating a similar conformation
and folding of the two proteins. These data confirmed a
similar immunoreactivity of the two proteins indicating that
187GAD65mut is suitable as an oral vaccine candidate.
The average187GAD65mut expression level in red beet leaves
was 201.4 ± 29.3 µg/g FLW, which is sufficient to commence
the development of a T1D oral vaccine that will be required in
large amounts, ranging from micrograms per day per animal
for preclinical studies in mouse models of T1D through to
milligrams per day per subject for human clinical trials, as
previously reported for recombinant oral insulin (Polanski et al.,
1997; Skyler et al., 2005). The average recombinant protein levels
produced in red beet leaves are consistent with previous results
in edible plant systems (Merlin et al., 2017). However, our novel
platform has several advantages. First, the magnICON R© system
produces the recombinant protein in a much shorter timeframe
(up to 2 weeks) compared to transgenic or transplastomic lettuce,
rice, carrots and maize (Uvarova et al., 2013; Fukuda et al., 2015;
Nahampun et al., 2015; Su et al., 2015). Second, the magnICON R©
system achieves higher yields than other transient expression
systems in edible species (Clarke et al., 2017). The production
of a massive amount of leaf tissue expressing the recombinant
protein for oral tolerance induction would therefore require
commensurate facilities for plant cultivation. Furthermore, the
magnICON R© system requires the continuous infiltration of plant
material. However, the protocol described herein is compatible
with continuous production and easily scalable, making it ideal
for the production of a T1D oral vaccine. On the basis of the yields
we achieved and the 70,000 children diagnosed each year with
T1D (International Diabetes Federation, 2006), we estimate that
42,000 red beet plants (corresponding to 200 m2 of greenhouse
space) would be sufficient to meet global demand for a T1D
secondary prevention strategy, assuming treatment comprises the
daily administration of 1 mg of187GAD65mut for 8 years.
Leafy tissues comprise more than 95% water, and this
environment encourages protein degradation and also the
proliferation of microbes. The effective delivery of large doses
of recombinant protein would therefore ideally be achieved
using dried plant tissue, to facilitate volume reduction, to
increase shelf life, and to reduce the bioburden. Our results
indicate that lyophilization meets all these requirements by
reducing the leaf water content by at least 10-fold (data not
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shown), by preserving the high 187GAD65mut yields recorded
before treatment, and by eliminating bacteria, including the
recombinant A. tumefaciens used during production. Although
contamination by viable microbes (bioburden) can be controlled,
the possibility exists that the processed leaf tissue may carry
bacterial lipopolysaccharide (LPS; endotoxin). The highest source
of potential residual endotoxin in the process described would be
from the vector, as Agrobacterium is a Gram-negative bacterium
with LPS present in its cell wall. It is important to emphasize
that although LPS is highly bioactive systemically in humans
and other mammals, it is not considered a high safety risk if
administered orally. Harper et al. (2011) showed that up to 1
million endotoxin units (EU) of LPS can be administered safely
to mice by oral gavage with no evidence of toxicity as assessed
by body weight effects, clinical signs, gross organ lesions at
necropsy, etc. Similarly, Wallace et al. (2016) reviewed the safety
of endotoxins on feed and occupational exposure in people and
found the risk to be low if exposure is via the oral route. This is
not surprising since humans are constantly exposed to endotoxin
from the 1012 bacterial cells/ml in their colon and have likely
become tolerized to LPS via commensalism (d’Hennezel et al.,
2017).
In this proof-of-principle study, we used a relatively high
ratio of inoculum to plant tissue and induced gene expression
via agroinfiltration. In an industrial setting, the production of
large quantities of GAD65 to meet market demand could be
achieved in transgenic red beet plants carrying the GAD65 gene
under control of an ethanol-inducible promoter (Werner et al.,
2011). Although transgenic lines remain to be constructed, such
a system offers the twin advantages of obviating (a) the cost of
manufacturing the agrobacterial inoculum by replacing it with a
low-cost inducer (e.g., dilute ethanol), and (b) the vector-borne
endotoxin.
The treated leaf tissue was evaluated to determine whether the
187GAD65mut protein was protected by bioencapsulation, but
our results indicated that the protein content of the tissue was
digested under the conditions found in the gastric environment.
We hypothesized that the lyophilization treatment damages
the plant cell wall and exposes the 187GAD65mut protein
to the acidic milieu and digestive enzymes present in the
stomach. Previous studies have shown that the oral delivery of
powdered tobacco leaves (not lyophilized) expressing a cholera
toxin fusion protein in the chloroplast makes the recombinant
protein bioavailable in the liver, intestinal mucosa and spleen, but
quantitative bioavailability data were not presented (Limaye et al.,
2006).
Our results suggest that, for the proposed application, the
freeze-dried/lyophilized leaf material should be formulated in
order to overcome the gastric environment and to be released
in the intestine. Recent studies with oral delivered insulin
demonstrated that synthetic hydrogels, three-dimensional mesh
like networks containing hydrophilic polymers (Renukuntla
et al., 2013), may fulfill these requirements (Tuesca et al., 2008).
PCA was used to evaluate the metabolic bioequivalence
of plants expressing 187GAD65mut compared to infiltrated
and non-infiltrated controls, revealing no significant difference
between the infiltrated plants expressing 187GAD65mut and
the infiltrated controls, whereas the non-infiltrated wild-type
plants formed a separate cluster. This shows that certain primary
and secondary metabolites distinguish infiltrated plants from
untreated plants, but the presence of 187GAD65mut has little
overall impact. These results may indicate that the LC-MS
analysis identified bacterial metabolites, or metabolites produced
by the infiltrated plants as defense/stress-response signals. The
infiltration of red beet plants with A. tumefaciens (Hellens et al.,
2000) triggers the production of reactive oxygen species (ROS)
after 24 h (Sepúlveda-Jiménez et al., 2005). In turn, ROS are
known to induce defense mechanisms that modulate the levels of
certain metabolites. Among the secondary metabolites identified
by PCA, sinapic acid and kaempferol derivatives protect plants
against UV-B stress (Li et al., 1993), and anthocyanins acylated
with caffeic acid and certain caffeic and coumaric acid derivatives
might protect cultured plant cells from heat stress (Commisso
et al., 2016). There was no significant difference among the
three groups of plants in terms of polar lipid profiles, indicating
that such metabolites are not affected by agroinfiltration or the
expression of187GAD65mut.
Overall, our results suggest that freeze-dried/lyophilized red
beet plants are suitable for the safe and cost-effective production
of vaccine candidates for the future clinical testing of T1D oral
immunotherapy.
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